The FDA Commissioner Highlighted a New CDC Report Citing ‘No Evidence’ Of Chronic Opioid Benefit When Discussing Potential Labeling Changes. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
